Comments on ALLHAT and doxazosin
Abstract This commentary has two purposes: to summarize the rationale, design and initial results of the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) trial; and to provide Control Board a history of the response to ALLHAT that led to a civil action and a Citizens Petition that was the basis for a public heari